Status:
COMPLETED
Comparison of 4 Tactical Tourniquets Used in War Medicine
Lead Sponsor:
Direction Centrale du Service de Santé des Armées
Conditions:
Hemorrhage
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Bleeding remains the leading cause of death in combat, and the literature suggests that tourniquetable hemorrhage is the second leading cause of preventable death, behind non- tourniquetable hemorrhag...
Eligibility Criteria
Inclusion
- Age ≥ 18 years;
- Student of the Military Health School of Lyon Bron (Ecoles Militaires de Santé de Lyon Bron; EMSLB);
- Periodic medical examination up to date with the mention "fitness for duty";
- Holder of the "Combat Rescue Level 1" training.
Exclusion
- Vascular pathology;
- Current progressive pathology of any kind;
- History of thrombo-embolic disease;
- Presence of cardiovascular risk factors (diabetes, hypertension, dyslipidemia, smoking \> 1 cigarette/day, BMI \> 25);
- Iliofemoral and axillary vascular abnormalities detected by systematic Doppler ultrasound;
- Presence of symptoms suggestive of COVID-19;
- Positive COVID-19 antigen test;
- In contact with a person diagnosed positive for COVID-19 within 15 days prior to inclusion;
- Pregnant or breastfeeding woman.
Key Trial Info
Start Date :
May 28 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 14 2021
Estimated Enrollment :
46 Patients enrolled
Trial Details
Trial ID
NCT04870814
Start Date
May 28 2021
End Date
June 14 2021
Last Update
July 7 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital d'Instruction des Armées Desgenettes
Lyon, France, 69003